Skip to main content
SpringerLink
Log in

Autoimmunity and Brain Dysfunction

  • Chapter
The Neuroimmunological Basis of Behavior and Mental Disorders

  • 1359 Accesses

Abstract

This chapter summarizes current knowledge on the relationship between systemic autoimmune/inflammatory processes, brain pathology, and mental (dys) function. Several lines of evidence are presented, as well as the molecular mechanisms instrumental in the initiation and maintenance of complex pathogenic circuits. Although the emphasis is on systemic lupus erythematosus and its associated neuropsychiatric manifestations, other disorders relevant to the immunological theory of mental disorders are also reviewed. Together with relevant immunopathology, the associated permissive conditions (e.g., breached blood-brain barrier) are discussed in the context of an upregulation in brain-reactive autoantibodies, neuroactive cytokines, complement components, and immune complexes. The gaps in our present knowledge and future directions are outlined at the end of the chapter.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Abbott NJ, Mendonca LL, Dolman DE, 2003. The blood-brain barrier in systemic lupus erythematosus. Lupus 12:908–915.

    PubMed  CAS  Google Scholar 

  • ACR Ad Hoc Committee, 1999. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum. 42:599–608.

    Google Scholar 

  • Afeltra A, Garzia P, Mitterhofer AP, Vadacca M, Galluzzo S, Del PF, Finamore L, Pascucci S, Gasparini M, Lagana B, Caccavo D, Ferri GM, Amoroso A, Francia A, 2003. Neuropsychiatric lupus syndromes: relationship with antiphospholipid antibodies. Neurology 61:108–110.

    PubMed  Google Scholar 

  • Ahlsen G, Rosengren L, Belfrage M, Palm A, Haglid K, Hamberger A, Gillberg C, 1993. Glial fibrillary acidic protein in the cerebrospinal fluid of children with autism and other neuropsychiatric disorders. Biol. Psychiatry 33:734–743.

    PubMed  CAS  Google Scholar 

  • Ainiala H, Hietaharju A, Dastidar P, Loukkola J, Lehtimaki T, Peltola J, Korpela M, Heinonen T, Nikkari ST, 2004. Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities. Arthritis Rheum. 50:858–865.

    PubMed  CAS  Google Scholar 

  • Ainiala H., Loukkola J., Peltola J., Korpela M., Hietaharju A., 2001. The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus. Neurology 57:496–500.

    PubMed  CAS  Google Scholar 

  • Alcocer-Varela J, Aleman-Hoey D, Alarcon-Segovia D, 1992. Interleukin-1 and interleukin-6 activities are increased in the cerebrospinal fluid of patients with CNS lupus erythematosus and correlate with local late T-cell activation markers. Lupus 1:111–117.

    PubMed  CAS  Google Scholar 

  • Alexander JJ, Bao L, Jacob A, Kraus DM, Holers VM, Quigg RJ, 2003. Administration of the soluble complement inhibitor, Crry-Ig, reduces inflammation and aquaporin 4 expression in lupus cerebritis. Biochim. Biophys. Acta 1639: 69–176.

    Google Scholar 

  • Alexander JJ, Jacob A, Bao L, Macdonald RL, Quigg RJ, 2005a. Complement-dependent apoptosis and inflammatory gene changes in murine lupus cerebritis. J. Immunol. 175:8312–8319.

    CAS  Google Scholar 

  • Alexander JJ, Jacob A, Vezina P, Sekine H, Gilkeson GS, Quigg RJ, 2007. Absence of functional alternative complement pathway alleviates lupus cerebritis. Eur. J. Immunol. 37:1691–1701.

    PubMed  CAS  Google Scholar 

  • Alexander EL, Murphy ED, Roths JB, Alexander GE, 1983. Congenic autoimmune murine models of central nervous system disease in connective tissue disorders. Ann. Neurol. 14:242–248.

    PubMed  CAS  Google Scholar 

  • Alexander JJ, Quigg RJ, 2007. Systemic lupus erythematosus and the brain: what mice are telling us. Neurochem. Int. 50:5–11.

    PubMed  CAS  Google Scholar 

  • Alexander JJ, Zwingmann C, Quigg R, 2005b. MRL/lpr mice have alterations in brain metabolism as shown with [(1)H-(13)C] NMR spectroscopy. Neurochem. Int. 47:143–151.

    CAS  Google Scholar 

  • Alosachie IJ, Terryberry JW, Mevorach D, Chapman Y, Lorber M, Torre D, Youinou P, Peter JB, Shoenfeld Y, 1998. Central nervous system (CNS) involvement in SLE. The diagnostic role of antibodies to neuronal antigens. Clin. Rev. Allergy Immunol. 16:275–284.

    PubMed  CAS  Google Scholar 

  • Anderson KK, Ballok DA, Prasad N, Szechtman H, Sakic B, 2006. Impaired response to amphetamine and neuronal degeneration in the nucleus accumbens of autoimmune MRL-lpr mice. Behav. Brain Res. 166:32–38.

    PubMed  CAS  Google Scholar 

  • Anisman H, Merali Z, Poulter MO, Hayley S, 2005. Cytokines as a precipitant of depressive illness: animal and human studies. Curr. Pharm. Des. 11:963–972.

    PubMed  CAS  Google Scholar 

  • Appenzeller S, Bonilha L, Rio PA, Min LL, Costallat LT, Cendes F, 2007. Longitudinal analysis of gray and white matter loss in patients with systemic lupus erythematosus. Neuroimage. 34:694–701.

    PubMed  Google Scholar 

  • Arolt V, Weitzsch C, Wilke I, Nolte A, Pinnow M, Rothermundt M, Kirchner H, 1997. Production of interferon-gamma in families with multiple occurrence of schizophrenia. Psychiatry Res. 66:145–152.

    PubMed  CAS  Google Scholar 

  • Avcin T, Silverman ED, 2007. Antiphospholipid antibodies in pediatric systemic lupus erythematosus and the antiphospholipid syndrome. Lupus 16:627–633.

    PubMed  CAS  Google Scholar 

  • Ballok DA, 2007. Neuroimmunopathology in a murine model of neuropsychiatric lupus. Brain Res. Rev. 54:67–79.

    PubMed  CAS  Google Scholar 

  • Ballok DA, Earls AM, Krasnik C, Hoffman SA, Sakic B, 2004a. Autoimmune-induced damage of the midbrain dopaminergic system in lupus-prone mice. J. Neuroimmunol. 152:83–97.

    CAS  Google Scholar 

  • Ballok DA, Ma X, Denburg JA, Arsenault L, Sakic B, 2006. Ibuprofen fails to prevent brain pathology in a model of neuropsychiatric lupus. J. Rheumatol. 33:2199–2213.

    PubMed  CAS  Google Scholar 

  • Ballok DA, Sakic B. Neurodegeneration in autoimmune mice as revealed by Fluoro Jade B. Society for Neuroscience Abstracts, 93.15. 2002. Ref Type: Abstract

    Google Scholar 

  • Ballok DA, Woulfe J, Sur M, Cyr M., Sakic B, 2004b. Hippocampal damage in mouse and human forms of systemic autoimmune disease. Hippocampus 14:649–661.

    Google Scholar 

  • Baraczka K, Nekam K, Pozsonyi T, Jakab L, Szongoth M, Sesztak M, 2001. Concentration of soluble adhesion molecules (sVCAM-1, sICAM-1 and sL-selectin) in the cerebrospinal fluid and serum of patients with multiple sclerosis and systemic lupus erythematosus with central nervous involvement. Neuroimmunomodulation. 9:49–54.

    PubMed  CAS  Google Scholar 

  • Baraczka K, Nekam K, Pozsonyi T, Szuts I, Ormos G, 2004. Investigation of cytokine (tumor necrosis factor-alpha, interleukin-6, interleukin-10) concentrations in the cerebrospinal fluid of female patients with multiple sclerosis and systemic lupus erythematosus. Eur. J. Neurol. 11:37–42.

    PubMed  CAS  Google Scholar 

  • Bartholomew SA, Hoffman SA, 1993. Effects of peripheral cytokine injections on multiple unit activity in the anterior hypothalamic area of the mouse. Brain Behav. Immun. 7:301–316.

    PubMed  CAS  Google Scholar 

  • Beiske AG, Svensson E, Sandanger I, Czujko B, Pedersen ED, Aarseth JH, Myhr KM, 2008. Depression and anxiety amongst multiple sclerosis patients. Eur. J. Neurol. 15:239–245.

    PubMed  CAS  Google Scholar 

  • Belmont HM, Hopkins P, Edelson HS, Kaplan HB, Ludewig R, Weissmann G, Abramson S, 1986. Complement activation during systemic lupus erythematosus – C3a and C5a anaphylatoxins circulate during exacerbations of disease. Arthritis Rheum. 29:1085–1089.

    PubMed  CAS  Google Scholar 

  • Bluestein HG, 1978. Neurocytotoxic antibodies in serum of patients with systemic lupus erythematosus. Proc. Natl. Acad. Sci. U. S. A. 75:3965–3969.

    PubMed  CAS  Google Scholar 

  • Bluestein HG, 1979. Heterogeneous neurocytotoxic antibodies in systemic lupus erythematosus. Clin. Exp. Immunol. 35:210.

    PubMed  CAS  Google Scholar 

  • Bluestein HG, Pischel KD, Woods VL, Jr., 1986. Immunopathogenesis of the neuropsychiatric manifestations of systemic lupus erythematosus. Springer Semin. Immunopathol. 9:237–249.

    PubMed  CAS  Google Scholar 

  • Bluestein HG, Williams GW, Steinberg AD, 1981. Cerebrospinal fluid antibodies to neuronal cells: association with neuropsychiatric manifestations of systemic lupus erythematosus. Am. J. Med. 70:240–246.

    PubMed  CAS  Google Scholar 

  • Bluestein HG, Woods VL, 1982. Antineuronal antibodies in systemic lupus erythematosus. Arthritis Rheum. 25:773–778.

    PubMed  CAS  Google Scholar 

  • Bluestein HG, Zvaifler NJ, 1976. Brain-reactive lymphocytotoxic antibodies in the serum of patients with systemic lupus erythematosus. J. Clin. Invest. 57:509–516.

    PubMed  CAS  Google Scholar 

  • Blum D, Torch S, Lambeng N, Nissou M, Benabid AL, Sadoul R, Verna JM, 2001. Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson’s disease. Prog. Neurobiol. 65:135–172.

    PubMed  CAS  Google Scholar 

  • Borchers AT, Aoki CA, Naguwa SM, Keen CL, Shoenfeld Y, Gershwin ME, 2005. Neuropsychiatric features of systemic lupus erythematosus. Autoimmun. Rev. 4:329–344.

    PubMed  CAS  Google Scholar 

  • Borda T, Perez RR, Joensen L, Gomez RM, Sterin-Borda L, 2002. Antibodies against cerebral M1 cholinergic muscarinic receptor from schizophrenic patients: molecular interaction. J. Immunol. 168:3667–3674.

    PubMed  CAS  Google Scholar 

  • Bosma GP, Rood MJ, Zwinderman AH, Huizinga TW, van Buchem MA, 2000. Evidence of central nervous system damage in patients with neuropsychiatric systemic lupus erythematosus, demonstrated by magnetization transfer imaging. Arthritis Rheum. 43:48–54.

    PubMed  CAS  Google Scholar 

  • Bresnihan B, Hohmeister R, Cutting J, Travers RL, Waldburger M, Black C, Jones T, Hughes GR, 1979. The neuropsychiatric disorder in systemic lupus erythematosus: evidence for both vascular and immune mechanisms. Ann. Rheum. Dis. 38:301–306.

    PubMed  CAS  Google Scholar 

  • Brey RL, Cote S, Barohn R, Jackson C, Crawley R, Teale JM, 1995. Model for the neuromuscular complications of systemic lupus erythematosus. Lupus 4:209–212.

    PubMed  CAS  Google Scholar 

  • Brey RL, Holliday SL, Saklad AR, Navarrete MG, Hermosillo-Romo D, Stallworth CL, Valdez CR, Escalante A, del RI, Gronseth G, Rhine CB, Padilla P, McGlasson D, 2002. Neuropsychiatric syndromes in lupus: prevalence using standardized definitions. Neurology 58:1214–1220.

    PubMed  CAS  Google Scholar 

  • Brey RL, Sakic B, Szechtman H, Denburg JA, 1997. Animal models for nervous system disease in systemic lupus erythematosus. Ann. N. Y. Acad. Sci. 823:97–106.

    PubMed  CAS  Google Scholar 

  • Brooks WM, Sabet A, Sibbitt WL, Barker PB, van Zijl PC, Duyn JH, Moonen CT, 1997. Neurochemistry of brain lesions determined by spectroscopic imaging in systemic lupus erythematosus. J. Rheumatol. 24:2323–2329.

    PubMed  CAS  Google Scholar 

  • Bruns A, Meyer O, 2006. Neuropsychiatric manifestations of systemic lupus erythematosus. Joint Bone Spine 73:639–645.

    PubMed  Google Scholar 

  • Buka SL, Cannon TD, Torrey EF, Yolken RH, 2008. Maternal exposure to herpes simplex virus and risk of psychosis among adult offspring. Biol. Psychiatry. 63:809–815.

    PubMed  Google Scholar 

  • Buka SL, Tsuang MT, Torrey EF, Klebanoff MA, Bernstein D, Yolken RH, 2001. Maternal infections and subsequent psychosis among offspring. Arch. Gen. Psychiatry 58:1032–1037.

    PubMed  CAS  Google Scholar 

  • Callenbach PM, Jol-Van Der Zijde CM, Geerts AT, Arts WF, Van Donselaar CA, Peters AC, Stroink H, Brouwer OF, Van Tol MJ, 2003. Immunoglobulins in children with epilepsy: the Dutch Study of Epilepsy in Childhood. Clin. Exp. Immunol. 132:144–151.

    PubMed  CAS  Google Scholar 

  • Carbotte RM, Denburg SD, Denburg JA, 1986. Prevalence of cognitive impairment in systemic lupus erythematosus. J. Nerv. Ment. Dis. 174:357–364.

    PubMed  CAS  Google Scholar 

  • Carr RI, Shucard DW, Hoffman SA, Hoffman AW, Bardana EJ, Harbeck RJ, 1978. In Neurochemical and components of schizophrenia, Goldstein, A.L. and Bergsma, D.(Eds), Birth Defects Orig. Artic. Ser. 14: 209–235.

    Google Scholar 

  • Caspi A, Moffitt TE, 2006. Gene-environment interactions in psychiatry: joining forces with neuroscience. Nat. Rev. Neurosci. 7:583–590.

    PubMed  CAS  Google Scholar 

  • Cazzullo CL, Scarone S, Grassi B, Vismara C, Trabattoni D, Clerici M, 1998. Cytokines production in chronic schizophrenia patients with or without paranoid behaviour. Prog. Neuropsychopharmacol. Biol. Psychiatry 22:947–957.

    PubMed  CAS  Google Scholar 

  • Chess S, 1977. Follow-up report on autism in congenital rubella. J. Autism Child Schizophr. 7:69–81.

    PubMed  CAS  Google Scholar 

  • Chun S, McEvilly R, Foster JA, Sakic B, 2007. Proclivity to self-injurious behavior in MRLlpr mice: implications for autoimmunity-induced damage in the dopaminergic system. Mol. Psychiatry. 1359–4184.

    Google Scholar 

  • Comi AM, Zimmerman AW, Frye VH, Law PA, Peeden JN, 1999. Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism. J. Child Neurol. 14:388–394.

    PubMed  CAS  Google Scholar 

  • Conejero-Goldberg C, Torrey EF, Yolken RH, 2003. Herpesviruses and Toxoplasma gondii in orbital frontal cortex of psychiatric patients. Schizophr. Res. 60:65–69.

    PubMed  Google Scholar 

  • Connolly AM, Chez MG, Pestronk A, Arnold ST, Mehta S, Deuel RK, 1999. Serum autoantibodies to brain in Landau-Kleffner variant, autism, and other neurologic disorders. J. Pediatr. 134:607–613.

    PubMed  CAS  Google Scholar 

  • Correale J, Farez M, Gilmore W, 2008. Vaccines for multiple sclerosis – progress to date. CNS Drugs 22:175–198.

    PubMed  CAS  Google Scholar 

  • Crimando J, Cooper K, Hoffman SA, 1997. Inhibition of sodium channel currents by antineuronal autoantibody from autoimmune mice. Ann. N. Y. Acad. Sci. 823:303–307.

    PubMed  CAS  Google Scholar 

  • Cronin ME, Biswas RM, Van der Straeton C, Fleisher TA, Klippel JH, 1988. IgG and IgM anticardiolipin antibodies in patients with lupus with anticardiolipin antibody associated clinical syndromes. J. Rheumatol. 15:795–798.

    PubMed  CAS  Google Scholar 

  • Daniels WW, Warren RP, Odell JD, Maciulis A, Burger RA, Warren WL, Torres AR, 1995. Increased frequency of the extended or ancestral haplotype B44-SC30-DR4 in autism. Neuropsychobiology 32:120–123.

    PubMed  CAS  Google Scholar 

  • Danon YL, Garty BZ, 1986. Autoantibodies to neuroblastoma cell surface antigens in neuropsychiatric lupus. Neuropediatrics 17:23–27.

    PubMed  CAS  Google Scholar 

  • Davoust N, Jones J, Stahel PF, Ames RS, Barnum SR, 1999. Receptor for the C3a anaphylatoxin is expressed by neurons and glial cells. Glia 26:201–211.

    PubMed  CAS  Google Scholar 

  • DeGiorgio LA, Konstantinov KN, Lee SC, Hardin JA, Volpe BT, Diamond B, 2001. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat. Med. 7:1189–1193.

    PubMed  CAS  Google Scholar 

  • Denburg JA, Carbotte RM, Denburg SD, 1993. Central nervous system lupus. Rheum. Rev. 2:123–132.

    Google Scholar 

  • Denburg SD, Carbotte RM, Ginsberg JS, Denburg JA, 1997. The relationship of antiphospholipid antibodies to cognitive function in patients with systemic lupus erythematosus. J. Int. Neuropsychol. Soc. 3:377–386.

    PubMed  CAS  Google Scholar 

  • Denburg JA, Denburg SD, Carbotte RM, Long AA, Hanly JG, 1988. Nervous system involvement in systemic lupus erythematosus. Isr. J. Med. Sci. 24:754–758.

    PubMed  CAS  Google Scholar 

  • Denburg JA, Denburg SD, Carbotte RM, Sakic B, Szechtman H, 1995. Nervous system lupus: pathogenesis and rationale for therapy. Scand. J. Rheumatol. 12:263–273.

    Google Scholar 

  • Denenberg VH, Mobraaten LE, Sherman GF, Morrison L, Schrott LM, Waters NS, Rosen GD, Behan PO, Galaburda AM, 1991. Effects of the autoimmune uterine/maternal environment upon cortical ectopias, behavior and autoimmunity. Brain Res. 563:114–122.

    PubMed  CAS  Google Scholar 

  • Denenberg VH, Sherman GF, Morrison L, Schrott LM, Waters NS, Rosen GD, Behan PO, Galaburda AM, 1992. Behavior, ectopias and immunity in BD/DB reciprocal crosses. Brain Res. 571:323–329.

    PubMed  CAS  Google Scholar 

  • Deykin EY, MacMahon B, 1979. Viral exposure and autism. Am. J. Epidemiol. 109:628–638.

    PubMed  CAS  Google Scholar 

  • Diederichsen H, Pyndt IC, 1970. Antibodies against neurons in a patient with systemic lupus erythematosus, cerebral palsy, and epilepsy. Brain 93:407–412.

    PubMed  CAS  Google Scholar 

  • Elouaai F, Lule J, Benoist H, Appolinaire-Pilipenko S, Atanassov C, Muller S, Fournie GJ, 1994. Autoimmunity to histones, ubiquitin, and ubiquitinated histone H2A in NZB x NZW and MRL-lpr/lpr mice. Anti-histone antibodies are concentrated in glomerular eluates of lupus mice. Nephrol. Dial. Transplant. 9:362–366.

    PubMed  CAS  Google Scholar 

  • Farrell M, Sakic B, Szechtman H, Denburg JA, 1997. Effect of cyclophosphamide on leucocytic infiltration in the brain of MRL/lpr mice. Lupus 6:268–274.

    PubMed  CAS  Google Scholar 

  • Feinstein A, 2004. The neuropsychiatry of multiple sclerosis. Can. J. Psychiatry 49:157–163.

    PubMed  Google Scholar 

  • Feinstein A, Feinstein K, Gray T, O’Connor P, 1997. Prevalence and neurobehavioral correlates of pathological laughing and crying in multiple sclerosis. Arch. Neurol. 54:1116–1121.

    PubMed  CAS  Google Scholar 

  • Feinstein A, O’Connor P, Gray T, Feinstein K, 1999. The effects of anxiety on psychiatric morbidity in patients with multiple sclerosis. Mult. Scler. 5:323–326.

    PubMed  CAS  Google Scholar 

  • Ferro JM, 1998. Vasculitis of the central nervous system. J. Neurol. 245:766–776.

    PubMed  CAS  Google Scholar 

  • Fessel WJ, 1962a. Autoimmunity and mental illness. A preliminary report. Arch. Gen. Psychiatry 6:320–323.

    CAS  Google Scholar 

  • Fessel WJ, 1962b. Macroglobin elevations in functional mental illness. Nature 193:1005.

    CAS  Google Scholar 

  • Fessel WJ, Hirata-Hibi M, 1963. Abnormal leucocytes in schizophrenia. Arch. Gen. Psychiatry 106:601–613.

    Google Scholar 

  • Fields RA, Sibbitt WL, Toubbeh H, Bankhurst AD, 1990. Neuropsychiatric lupus erythematosus, cerebral infarctions, and anticardiolipin antibodies. Ann. Rheum. Dis. 49:114–117.

    PubMed  CAS  Google Scholar 

  • Fieschi C, Rasura M, Anzini A, Beccia M, 1998. Central nervous system vasculitis. J. Neurol. Sci. 153:159–171.

    PubMed  CAS  Google Scholar 

  • Forster MJ, Popper MD, Retz KC, Lal H, 1988a. Age differences in acquisition and retention of one-way avoidance learning in C57BL/6NNia and autoimmune mice. Behav. Neural Biol. 49:139–151.

    CAS  Google Scholar 

  • Forster MJ, Retz KC, Lal H, 1988b. Learning and memory deficits associated with autoimmunity: significance in aging and Alzheimer’s disease. Drug Dev. Res. 15:253–273.

    Google Scholar 

  • Francis K, Lewis BM, Akatsu H, Monk PN, Cain SA, Scanlon MF, Morgan BP, Ham J, Gasque P, 2003. Complement C3a receptors in the pituitary gland: a novel pathway by which an innate immune molecule releases hormones involved in the control of inflammation. FASEB J. online.

    Google Scholar 

  • Ganguli R, Brar JS, Chengappa KN, Yang ZW, Nimgaonkar VL, Rabin BS, 1993. Autoimmunity in schizophrenia: a review of recent findings. Ann. Med. 25:489–496.

    PubMed  CAS  Google Scholar 

  • Ganguli R, Brar JS, Rabin BS, 1994. Immune abnormalities in schizophrenia: evidence for the autoimmune hypothesis. Harv. Rev. Psychiatry 2:70–83.

    PubMed  CAS  Google Scholar 

  • Gaughran F, 2002. Immunity and schizophrenia: autoimmunity, cytokines, and immune responses. Int. Rev. Neurobiol. 52:275–302.

    PubMed  CAS  Google Scholar 

  • Ghaffar O, Feinstein A, 2007. The neuropsychiatry of multiple sclerosis: a review of recent developments. Curr. Opin. Psychiatry 20:278–285.

    PubMed  Google Scholar 

  • Gianani R, Sarvetnick N, 1996. Viruses, cytokines, antigens, and autoimmunity. Proc. Natl. Acad. Sci. U. S. A. 93:2257–2259.

    PubMed  CAS  Google Scholar 

  • Gillberg C, 1999. Neurodevelopmental processes and psychological functioning in autism. Dev. Psychopathol. 11:567–587.

    PubMed  CAS  Google Scholar 

  • Gitlits VM, Sentry JW, Matthew ML, Smith AI, Toh BH, 2001. Synapsin I identified as a novel brain-specific autoantigen. J. Invest. Med. 49:283.

    Google Scholar 

  • Giuliani F, Goodyer CG, Antel JP, Yong VW, 2003. Vulnerability of human neurons to T cellmediated cytotoxicity. J. Immunol. 171:368–379.

    PubMed  CAS  Google Scholar 

  • Golombek SJ, Graus G, Elkon KB, 1986. Autoantibodies in the cerebrospinal fluid of patients with systemic lupus erythematosus. Arthritis Rheum. 29:1090–1097.

    PubMed  CAS  Google Scholar 

  • Greenwood DL, Gitlits VM, Alderuccio F, Sentry JW, Toh BH, 2002. Autoantibodies in neuropsychiatric lupus. Autoimmunity 35:79–86.

    PubMed  CAS  Google Scholar 

  • Gruol DL, Nelson TE, 1997. Physiological and pathological roles of interleukin-6 in the central nervous system. Mol. Neurobiol. 15:307–339.

    PubMed  CAS  Google Scholar 

  • Gwag BJ, Koh JY, Demaro JA, Ying HS, Jacquin M, Choi DW, 1997. Slowly triggered excitotoxicity occurs by necrosis in cortical cultures. Neuroscience 77:393–401.

    PubMed  CAS  Google Scholar 

  • Handa R, Sahota P, Kumar M, Jagannathan NR, Bal CS, Gulati M, Tripathi BM, Wali JP, 2003. In vivo proton magnetic resonance spectroscopy (MRS) and single photon emission computerized tomography (SPECT) in systemic lupus erythematosus (SLE). Magn Reson. Imaging 21:1033–1037.

    PubMed  CAS  Google Scholar 

  • Hanly JG, Fisk JD, Eastwood B, 1994. Brain reactive autoantibodies and cognitive impairment in systemic lupus erythematosus. Lupus 3:193–199.

    PubMed  CAS  Google Scholar 

  • Hanly JG, Fisk JD, McCurdy G, Fougere L, Douglas JA, 2005. Neuropsychiatric syndromes in patients with systemic lupus erythematosus and rheumatoid arthritis. J. Rheumatol. 32:1459–6.

    PubMed  Google Scholar 

  • Hanly JG, Hong C, 1993. Antibodies to brain integral membrane proteins in systemic lupus erythematosus. J. Immunol. Methods 161:107–118.

    PubMed  CAS  Google Scholar 

  • Harbeck R, Hoffman AA, Hoffman SA, 1978a. Distribution in isolated brain components of antigens combining with thymocytotoxins in New Zealand mice. Transplantation 25:161–163.

    CAS  Google Scholar 

  • Harbeck RJ, Hoffman AA, Hoffman SA, Shucard DW, 1979. Cerebrospinal fluid and the choroid plexus during acute immune complex disease. Clin. Immunol. Immunopathol. 13:413–425.

    PubMed  CAS  Google Scholar 

  • Harbeck RJ, Hoffman AA, Hoffman SA, Shucard DW, Carr RI, 1978b. A naturally occurring antibody in New Zealand mice cytotoxic to dissociated cerebellar cells. Clin. Exp. Immunol. 31:313–320.

    CAS  Google Scholar 

  • Harel Y, Barak Y, Achiron A, 2007. Dysregulation of affect in multiple sclerosis: new phenomenological approach. Psychiatry Clin. Neurosci. 61:94–98.

    PubMed  Google Scholar 

  • Harris EN, Hughes GRV, 1985. Cerebral disease in systemic lupus erythematosus. Springer Semin. Immunopathol. 8:251–266.

    PubMed  CAS  Google Scholar 

  • Hayley S, Anisman H, 2005. Multiple mechanisms of cytokine action in neurodegenerative and psychiatric states: neurochemical and molecular substrates. Curr. Pharm. Des. 11: 947–962.

    PubMed  CAS  Google Scholar 

  • Heath RG, 1969. Schizophrenia: evidence of a pathologic immune mechanism. Proc. Annu. Meet. Am. Psychopathol. Assoc. 58:234–252.

    PubMed  CAS  Google Scholar 

  • Heath RG, Krupp IM, 1967. Schizophrenia as an immunologic disorder. I. Demonstration of antibrain globulins by fluorescent antibody techniques. Arch. Gen. Psychiatry 16:1–9.

    PubMed  CAS  Google Scholar 

  • Henneberg A, Mayle DM, Kornhuber HH, 1991. Antibodies to brain tissue in sera of patients with chronic progressive multiple sclerosis. J. Neuroimmunol. 34:223–227.

    PubMed  CAS  Google Scholar 

  • Hess DC, Taormina M, Thompson J, Sethi KD, Diamond B, Rao R, Feldman DS, 1993. Cognitive and neurologic deficits in the MRL/lpr mouse: a clinicopathologic study. J. Rheumatol. 20:610–617.

    PubMed  CAS  Google Scholar 

  • Hickey WF, 1999. Leukocyte traffic in the central nervous system: the participants and their roles. Semin. Immunol. 11:125–137.

    PubMed  CAS  Google Scholar 

  • Hickey WF, 2001. Basic principles of immunological surveillance of the normal central nervous system. Glia 36:118–124.

    PubMed  CAS  Google Scholar 

  • Hickey WF, Lassmann S, Cross AH, 1997. Lymphocyte entry and the initiation of inflammation in the central nervous system. In: Keane, R.W., Hickey, W.F. (Eds.), Immunology of the Nervous System. Oxford University Press, New York, pp. 200–225.

    Google Scholar 

  • Hill PG, McMillan SA, 2006. Anti-tissue transglutaminase antibodies and their role in the investigation of coeliac disease. Ann. Clin. Biochem. 43:105–117.

    PubMed  CAS  Google Scholar 

  • Hirano T, Hashimoto H, Shiokawa Y, Iwamori M, Nagai Y, Kasi M, Ochiai Y, Okumura K, 1980. Antiglycolipid autoantibody detected in the sera from systemic lupus erythematosus patients. J. Clin. Invest. 66:1440.

    Google Scholar 

  • Hirohata S, Hirose S, Miyamoto T, 1985. Cerebrospinal fluid IgM, IgA, and IgG indexes in systemic lupus erythematosus. Their use as estimates of central nervous system disease activity. Arch. Intern. Med. 145:1843–1846.

    PubMed  CAS  Google Scholar 

  • Hirohata S, Miyamoto T, 1990. Elevated levels of interleukin-6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous system involvement. Arthritis Rheum. 33:644–649.

    PubMed  CAS  Google Scholar 

  • Hoffman SA, Arbogast DN, Day TT, Shucard DW, Harbeck RJ, 1983. Permeability of the blood cerebrospinal fluid barrier during acute immune complex disease. J. Immunol. 130:1695–1698.

    PubMed  CAS  Google Scholar 

  • Hoffman SA, Arbogast DN, Ford PM, Shucard DW, Harbeck RJ, 1987. Brain-reactive autoantibody levels in the sera of ageing autoimmune mice. Clin. Exp. Immunol. 70:74–83.

    PubMed  CAS  Google Scholar 

  • Hoffman SA, Ford P, Kubo R, 1988a. Characterization of cell surface antigens on the adrenergic neuroblastoma clone A2(1). Brain Res. 452:358–366.

    CAS  Google Scholar 

  • Hoffman SA, Harbeck RJ, 1989. CNS lupus and the blood-brain barrier. In: Neuwelt, E. A. (Ed.), Implications of the Blood-Brain Barrier and Its Manipulation. Plenum Medical Book Co., New York-London, pp. 469–494.

    Google Scholar 

  • Hoffman SA, Hoffman AA, Shucard DW, Harbeck RJ, 1978a. Antibodies to dissociated cerebellar cells in New Zealand mice as demonstrated by immunofluorescence. Brain Res. 142:477–486.

    CAS  Google Scholar 

  • Hoffman SA, Madsen CS, 1990. Brain specific autoantibodies in murine models of systemic lupus erythematosus. J. Neuroimmunol. 30:229–237.

    PubMed  CAS  Google Scholar 

  • Hoffman SA, Narendran A, Shucard DW, Harbeck RJ, 1988b. Autoantibodies, immune complexes, and behavioral disorders: neuropsychiatric involvement in systemic lupus erythematosus. Drug Dev. Res. 15:237–251.

    Google Scholar 

  • Hoffman SA, Shucard DW, Brodie HA, Reifenrath C, Harbeck RJ, 1982. Suppression of water intake by immune complex formation in the hypothalamus. Implications for systemic lupus erythematosus. J. Neuroimmunol. 2:167–176.

    PubMed  CAS  Google Scholar 

  • Hoffman SA, Shucard DW, Harbeck RJ, 1998. The immune system can affect learning: chronic immune complex disease in a rat model. J. Neuroimmunol. 86:163–170.

    PubMed  CAS  Google Scholar 

  • Hoffman SA, Shucard DW, Harbeck RJ, Hoffman AA, 1978b. Chronic immune complex disease: behavioral and immunological correlates. J. Neuropathol. Exp. Neurol. 37:426–436.

    CAS  Google Scholar 

  • Hogan MJ, Brunet DG, Ford PM, Lillicrap D, 1988. Lupus anticoagulant, antiphospholipid antibodies and migraine. Can. J. Neurol. Sci. 15:420–425.

    PubMed  CAS  Google Scholar 

  • Hopkins P, Belmont HM, Buyon J, Philips M, Weissmann G, Abramson SB, 1988. Increased levels of plasma anaphylatoxins in systemic lupus erythematosus predict flares of the disease and may elicit vascular injury in lupus cerebritis. Arthritis Rheum. 31:632–641.

    PubMed  CAS  Google Scholar 

  • Hornig M, Weissenbock H, Horscroft N, Lipkin WI, 1999. An infection-based model of neurodevelopmental damage. Proc. Natl. Acad. Sci. U. S. A. 96:12102–12107.

    PubMed  CAS  Google Scholar 

  • Horwitz MS, Sarvetnick N, 1999. Viruses, host responses, and autoimmunity. Immunol. Rev. 169:241–253.

    PubMed  CAS  Google Scholar 

  • How A, Dent PB, Liao SK, Denburg JA, 1985. Antineuronal antibodies in neuropsychiatric systemic lupus erythematosus. Arthritis Rheum. 28:789–795.

    PubMed  CAS  Google Scholar 

  • Huang WS, Chiu PY, Tsai CH, Kao A, Lee CC, 2002. Objective evidence of abnormal regional cerebral blood flow in patients with systemic lupus erythematosus on Tc-99m ECD brain SPECT. Rheumatol. Int. 22:178–181.

    PubMed  CAS  Google Scholar 

  • Huerta PT, Kowal C, DeGiorgio LA, Volpe BT, Diamond B, 2006. Immunity and behavior: antibodies alter emotion. Proc. Natl. Acad. Sci. U. S. A. 103:678–683.

    CAS  Google Scholar 

  • Inzelberg R, Korczyn A, 1989. Lupus anticoagulant and late onset seizures. Acta Neurol. Scand. 79:114–118.

    PubMed  CAS  Google Scholar 

  • James WG, Hutchinson P, Bullard DC, Hickey MJ, 2006. Cerebral leucocyte infiltration in lupusprone MRL/MpJ-fas lpr mice–roles of intercellular adhesion molecule-1 and P-selectin. Clin. Exp. Immunol. 144:299–308.

    PubMed  CAS  Google Scholar 

  • Jankovic BD, 1985. From immunoneurology to immunopsychiatry: neuromodulating activity of anti-brain antibodies. Int. Rev. Neurobiol. 26:249–314.

    PubMed  CAS  Google Scholar 

  • Jara LJ, Irigoyen L, Ortiz, MD, Zazueta B, Bravo G, Espinoza LR, 1998. Prolactin and interleukin- 6 in neuropsychiatric lupus erythematosus. Clin. Rheumatol. 17:110–114.

    PubMed  CAS  Google Scholar 

  • Jennekens FG, Kater L, 2002. The central nervous system in systemic lupus erythematosus. Part 2. Pathogenetic mechanisms of clinical syndromes: a literature investigation. Rheumatology (Oxford) 41:619–630.

    CAS  Google Scholar 

  • Johnson RT, Richardson EP, 1968. The neurological manifestations of systemic lupus erythematosus. Medicine 47:337–369.

    PubMed  CAS  Google Scholar 

  • Jongen PJ, Doesburg WH, Ibrahim-Stappers JL, Lemmens WA, Hommes OR, Lamers KJ, 2000. Cerebrospinal fluid C3 and C4 indexes in immunological disorders of the central nervous system. Acta Neurol. Scand. 101:116–121.

    PubMed  CAS  Google Scholar 

  • Jonsen A, Bengtsson AA, Nived O, Ryberg B, Truedsson L, Ronnblom L, Alm GV, Sturfelt G, 2003. The heterogeneity of neuropsychiatric systemic lupus erythematosus is reflected in lack of association with cerebrospinal fluid cytokine profiles. Lupus 12:846–850.

    PubMed  CAS  Google Scholar 

  • Kaposi MK, 1872. Neue Beitrage zur Kenntnis des Lupus erythematosus. Arch. Belg. Dermatol. Syphiligr. 4:36–52.

    Google Scholar 

  • Kasama T, Odai T, Wakabayashi K, Yajima N, Miwa Y, 2008. Chemokines in systemic lupus erythematosus involving the central nervous system. Front Biosci. 13:2527–2536.

    PubMed  CAS  Google Scholar 

  • Katsumata Y, Harigai M, Kawaguchi Y, Fukasawa C, Soejima M, Takagi K, Tanak M, Ichida H, Tochimoto A, Kanno T, Nishimura K, Kamatani N, Hara M, 2007. Diagnostic reliability of cerebral spinal fluid tests for acute confusional state (delirium) in patients with systemic lupus erythematosus: interleukin 6 (IL-6), IL-8, interferon-alpha, IgG index, and Q-albumin. J. Rheumatol. 34:2010–2017.

    PubMed  CAS  Google Scholar 

  • Katzav A, Solodeev I, Brodsky O, Chapman J, Pick CG, Blank M, Zhang W, Reichlin M, Shoenfeld Y, 2007. Induction of autoimmune depression in mice by anti-ribosomal P antibodies via the limbic system. Arthritis Rheum. 56:938–948.

    Google Scholar 

  • Keane RW, Hickey WF, 1997. Immunology of the Nervous System. Oxford University Press, New York.

    Google Scholar 

  • Kim RC, Collins GH, Parisi JE, 1982. Rheumatoid nodule formation within the choroid plexus. Report of a second case. Arch. Pathol. Lab. Med. 106:83–84.

    PubMed  CAS  Google Scholar 

  • Kirch DG, 1993. Infection and autoimmunity as etiologic factors in schizophrenia: a review and reappraisal. Schizophr. Bull. 19:355–370.

    PubMed  CAS  Google Scholar 

  • Kiss E, Shoenfeld Y, 2007. Are anti-ribosomal P protein antibodies relevant in systemic lupus erythematosus? Clin. Rev. Allergy Immunol. 69:37–46.

    Google Scholar 

  • Klein R, Richter C, Berg PA, 1991. Antibodies against central nervous system tissue (anti-CNS) detected by ELISA and western blotting: marker antibodies for neuropsychiatric manifestations in connective tissue diseases. Autoimmunity 10:133–144.

    PubMed  CAS  Google Scholar 

  • Komatsu N, Kodama K, Yamanouchi N, Okada S, Noda S, Nawata Y, Takabayashi K, Iwamoto I, Saito Y, Uchida Y, Ito H, Yoshikawa K, Sato T, 1999. Decreased regional cerebral metabolic rate for glucose in systemic lupus erythematosus patients with psychiatric symptoms. Eur. Neurol. 42:41–48.

    PubMed  CAS  Google Scholar 

  • Kowal C, DeGiorgio LA, Lee JY, Edgar MA, Huerta PT, Volpe BT, Diamond B, 2006. Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. Proc. Natl. Acad. Sci. U. S. A. 103:19854–19859.

    PubMed  CAS  Google Scholar 

  • Kowal C, DeGiorgio LA, Nakaoka T, Hetherington H, Huerta PT, Diamond B, Volpe BT, 2004. Cognition and immunity; antibody impairs memory. Immunity. 21:179–188.

    PubMed  CAS  Google Scholar 

  • Kozora E, Laudenslager M, Lemieux A, West SG, 2001. Inflammatory and hormonal measures predict neuropsychological functioning in systemic lupus erythematosus and rheumatoid arthritis patients. J. Int. Neuropsychol. Soc. 6:745–754.

    Google Scholar 

  • Kraepelin E, 1992. The manifestations of insanity. Hist. Psychiatry 3:509–526.

    Google Scholar 

  • Kronfol Z, Remick DG, 2000. Cytokines and the brain: implications for clinical psychiatry. Am. J. Psychiatry 157:683–694.

    PubMed  CAS  Google Scholar 

  • Kumar M, Cohen D, Eisdorfer C, 1988. Serum IgG brain reactive antibodies in Alzheimer disease and Down syndrome. Alzheimer Dis. Assoc. Disord. 2:50–55.

    PubMed  CAS  Google Scholar 

  • Kumar M, Resnick L, Loewenstein DA, Berger J, Eisdorfer C, 1989. Brain-reactive antibodies and the AIDS dementia complex. J. Acquir. Immune Defic. Syndr. 2:469–471.

    PubMed  CAS  Google Scholar 

  • Kurki P, Helve T, Dahl D, Virtanen I, 1986. Neurofilament antibodies in systemic lupus erythematosus. J. Rheumatol. 13:69–73.

    PubMed  CAS  Google Scholar 

  • Kwant A, Sakic B, 2004. Behavioral effects of infection with interferon-gamma adenovector. Behav. Brain Res. 151:73–82.

    PubMed  CAS  Google Scholar 

  • Lal H, Forster M, Retz KC, Reisberg B, 1988. Immune dysfunctions: new targets of drug discovery for Alzheimer’s disease and other cognitive disorders. Drug Dev. Res. 15.

    Google Scholar 

  • Lang B, Dale RC, Vincent A, 2003. New autoantibody mediated disorders of the central nervous system. Curr. Opin. Neurol. 16:351–357.

    PubMed  CAS  Google Scholar 

  • Lapteva L, Nowak M, Yarboro CH, Takada K, Roebuck-Spencer T, Weickert T, Bleiberg J, Rosenstein D, Pao M, Patronas N, Steele S, Manzano M, van d, V, Lipsky PE, Marenco S, Wesley R, Volpe B, Diamond B, Illei GG, 2006. Anti-N-methyl-D-aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus. Arthritis Rheum. 54:2505–2514.

    PubMed  CAS  Google Scholar 

  • Lawrence DA, Bolivar VJ, Hudson CA, Mondal TK, Pabello NG, 2007. Antibody induction of lupus-like neuropsychiatric manifestations. J Neuroimmunol 182:185–194.

    PubMed  CAS  Google Scholar 

  • Lawson LJ, Perry VH, Dri P, Gordon S, 1990. Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 39:151–170.

    PubMed  CAS  Google Scholar 

  • Layfield R, Lowe J, Bedford L, 2005. The ubiquitin-proteasome system and neurodegenerative disorders. Essays Biochem. 41:157–171.

    PubMed  CAS  Google Scholar 

  • Lehmann-Facius H, 1939. Serologisch-analytische Versuche mit Liquores und Seren von Schizophrenen. Allg. Z. Psychiatrie 110:232–243.

    Google Scholar 

  • Leweke FM, Gerth CW, Koethe D, Klosterkotter J, Ruslanova I, Krivogorsky B, Torrey EF, Yolken RH, 2004. Antibodies to infectious agents in individuals with recent onset schizophrenia. Eur. Arch. Psychiatry Clin. Neurosci. 254:4–8.

    PubMed  Google Scholar 

  • Liberato B, Levy RA, 2007. Antiphospholipid syndrome and cognition. Clin. Rev. Allergy Immunol. 32:188–191.

    PubMed  CAS  Google Scholar 

  • Lin A, Kenis G, Bignotti S, Tura GB, DeJong R, Bosmans E, Pioli R, Altamura C, Scharpe S, Maes M, 1998. The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6. Schizophr. Res. 32:9–15.

    PubMed  CAS  Google Scholar 

  • Long AA, Denburg SD, Carbotte RM, Singal DP, Denburg JA, 1990. Serum lymphocytotoxic antibodies and neurocognitive function in systemic lupus erythematosus. Ann. Rheum. Dis. 49:249–253.

    PubMed  CAS  Google Scholar 

  • Lopez-Longo FJ, Carol N, Almoguera MI, Olazaran J, onso-Farto JC, Ortega A, Monteagudo I, Gonzalez CM, Carreno L, 2003. Cerebral hypoperfusion detected by SPECT in patients with systemic lupus erythematosus is related to clinical activity and cumulative tissue damage. Lupus 12:813–819.

    PubMed  CAS  Google Scholar 

  • Ma X, Foster J, Sakic B, 2006. Distribution and prevalence of leukocyte phenotypes in brains of lupus-prone mice. J. Neuroimmunol. 179:26–36.

    PubMed  CAS  Google Scholar 

  • Maag TJ, Hoffman SA, 1993. Anti-brain antibodies in the sera of rheumatoid arthritis patients: relation to disease activity and psychological status. J. Neuroimmunol. 45:37–45.

    PubMed  CAS  Google Scholar 

  • Maes M, Delange J, Ranjan R, Meltzer HY, Desnyder R, Cooremans W, Scharpe S, 1997. Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs. Psychiatry Res. 66:1–11.

    PubMed  CAS  Google Scholar 

  • Maino K, Gruber R, Riedel M, Seitz N, Schwarz M, Muller N, 2007. T- and B-lymphocytes in patients with schizophrenia in acute psychotic episode and the course of the treatment. Psychiatry Res. 152:173–180.

    PubMed  CAS  Google Scholar 

  • Mamula MJ, 1998. Epitope spreading: the role of self peptides and autoantigen processing by B lymphocytes. Immunol. Rev. 164:231–239.

    PubMed  CAS  Google Scholar 

  • Margutti P, Delunardo F, Ortona E, 2006. Autoantibodies associated with psychiatric disorders. Curr. Neurovasc. Res. 3:149–157.

    PubMed  CAS  Google Scholar 

  • Maric D, Millward JM, Ballok DA, Szechtman H, Barker JL, Denburg JA, Sakic B, 2001. Neurotoxic properties of cerebrospinal fluid from behaviorally impaired autoimmune mice. Brain Res. 920:183–193.

    PubMed  CAS  Google Scholar 

  • McAllister CG, Rapaport MH, Pickar D, Paul SM, 1991. Autoimmunity and schizophrenia. In: Tamminga, C. A., Schultz, S. C. (Eds.), Advances in Neuropsychiatry and Psychopharmacology, vol. 1. Raven Press, Ltd., New York, pp. 111–118.

    Google Scholar 

  • McCluskey J, Farris AD, Keech CL, Purcell AW, Rischmueller M, Kinoshita G, Reynolds P, Gordon TP, 1998. Determinant spreading: lessons from animal models and human disease. Immunol. Rev. 164:209–229.

    PubMed  CAS  Google Scholar 

  • McIntyre KR, Ayer-LeLievre C, Persson H, 1990. Class II major histocompatibility complex (MHC) gene expression in the mouse brain is elevated in the autoimmune MRL/Mp-lpr/lpr strain. J. Neuroimmunol. 28:39–52.

    PubMed  CAS  Google Scholar 

  • McLean BN, Miller D, Thompson EJ, 1995. Oligoclonal banding of IgG in CSF, blood-brain barrier function, and MRI findings in patients with sarcoidosis, systemic lupus erythematosus, and Behcet’s disease involving the nervous system. J. Neurol. Neurosurg. Psychiatry 58:548–554.

    PubMed  CAS  Google Scholar 

  • Monastero R, Bettini P, Del Zotto E, Cottini E, Tincani A, Balestrieri G, Cattaneo R, Camarda R, Vignolo LA, Padovani A, 2001. Prevalence and pattern of cognitive impairment in systemic lupus erythematosus patients with and without overt neuropsychiatric manifestations. J. Neurol. Sci.: 33–39.

    Google Scholar 

  • Mondal TK, Saha SK, Miller VM, Seegal RF, Lawrence DA, 2008. Autoantibody-mediated neuroinflammation: Pathogenesis of neuropsychiatric systemic lupus erythematosus in the NZM88 murine model. Br. Behav. Immunity 22: 949–959.

    CAS  Google Scholar 

  • Money J, Bobrow NA, Clarke FC, 1971. Autism and autoimmune disease: a family study. J. Autism Child Schizophr. 1:146–160.

    PubMed  CAS  Google Scholar 

  • Monteleone P, Fabrazzo M, Tortorella A, Maj M, 1997. Plasma levels of interleukin-6 and tumor necrosis factor alpha in chronic schizophrenia: effects of clozapine treatment. Psychiatry Res. 71:11–17.

    PubMed  CAS  Google Scholar 

  • Moore PM, 1997. Autoantibodies to nervous system tissue in human and murine systemic lupus erythematosus. Ann. N. Y. Acad. Sci. 823:289–299.

    PubMed  CAS  Google Scholar 

  • Mora F, Segovia G, del Arco A, 2007. Aging, plasticity and environmental enrichment: Structural changes and neurotransmitter dynamics in several areas of the brain Brain Res. Rev. 55: 78–88.

    CAS  Google Scholar 

  • Mortensen PB, Norgaard-Pedersen B, Waltoft BL, Sorensen TL, Hougaard D, Torrey EF, Yolken RH, 2007. Toxoplasma gondii as a risk factor for early-onset schizophrenia: analysis of filter paper blood samples obtained at birth. Biol. Psychiatry 61:688–693.

    PubMed  Google Scholar 

  • Muller N, 1995. Psychoneuroimmunology: implications for the drug treatment of psychiatric disorders. CNS Drugs 4:125–140.

    Google Scholar 

  • Muller N, Ackenheil M, 1995. Immunoglobulin and albumin content of cerebrospinal fluid in schizophrenic patients: relationship to negative symptomatology. Schizophr. Res. 14:223–228.

    PubMed  CAS  Google Scholar 

  • Muller N, Empl M, Riedel M, Schwarz M, Ackenheil M, 1997. Neuroleptic treatment increases soluble IL-2 receptors and decreases soluble IL-6 receptors in schizophrenia. Eur. Arch. Psychiatry Clin. Neurosci. 247:308–313.

    PubMed  CAS  Google Scholar 

  • Muller N, Schlesinger BC, Hadjamu M, Riedel M, Schwarz M, Ackenheil M, Wank R, Gruber R, 1998. Increased frequency of CD8 positive gamma/delta T- lymphocytes (CD8(+) gamma/ delta(+)) in unmedicated schizophrenic patients: relation to impairment of the blood-brain barrier and HLA-DPA 02011. Schizophr. Res. 32:69–71.

    PubMed  CAS  Google Scholar 

  • Muller N, Schwarz M, 2006a. Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission. Neurotox. Res. 10:131–148.

    CAS  Google Scholar 

  • Muller N, Schwarz MJ, 2006b. Neuroimmune-endocrine crosstalk in schizophrenia and mood disorders. Expert. Rev. Neurother. 6:1017–1038.

    Google Scholar 

  • Nahmias AJ, Nahmias SB, Danielsson D, 2006. The possible role of transplacentally-acquired antibodies to infectious agents, with molecular mimicry to nervous system sialic acid epitopes, as causes of neuromental disorders: prevention and vaccine implications. Clin. Dev. Immunol. 13:167–183.

    PubMed  CAS  Google Scholar 

  • Narendran A, Hoffman SA, 1988. Identification of autoantibody reactive integral brain membrane antigens – a two dimensional analysis. J. Immunol. Methods 114:227–234.

    PubMed  CAS  Google Scholar 

  • Narendran A, Hoffman SA, 1989. Characterization of brain-reactive autoantibodies in murine models of systemic lupus erythematosus. J. Neuroimmunol. 24:113–123.

    PubMed  CAS  Google Scholar 

  • Nataf S, Davoust N, Barnum SR, 1998. Kinetics of C5aR expression during experimental allergic encephalomyelitis. J. Neuroimmunol. 91:147–155.

    PubMed  CAS  Google Scholar 

  • Naudin J, Mege JL, Azorin JM, Dassa D, 1996. Elevated circulating levels of IL-6 in schizophrenia. Schizophr. Res. 20:269–273.

    PubMed  CAS  Google Scholar 

  • Navarrete MG, Brey RL, 2000. Neuropsychiatric Systemic Lupus Erythematosus. Curr. Treat. Options. Neurol. 2:473–485.

    PubMed  Google Scholar 

  • Nikkila HV, Muller K, Ahokas A, Rimon R, Andersson LC, 2001. Increased frequency of activated lymphocytes in the cerebrospinal fluid of patients with acute schizophrenia. Schizophr. Res. 49:99–105.

    PubMed  CAS  Google Scholar 

  • Nishimura K, Harigai M, Omori M, Sato E, Hara M, 2008. Blood-brain barrier damage as a risk factor for corticosteroid-induced psychiatric disorders in systemic lupus erythematosus. Psychoneuroendocrinology. 33:395–403.

    PubMed  CAS  Google Scholar 

  • Omdal R, Brokstad K, Waterloo K, Koldingsnes W, Jonsson R, Mellgren SI, 2005. Neuropsychiatric disturbances in SLE are associated with antibodies against NMDA receptors. Eur. J. Neurol. 12:392–398.

    PubMed  CAS  Google Scholar 

  • Omdal R, Selseth B, Klow NE, Husby G, Mellgren SI, 1989. Clinical neurological, electrophysiological, and cerebral CT scan findings in systemic lupus erythematosus. Scand. J. Rheumatol. 18:283–289.

    PubMed  CAS  Google Scholar 

  • O’Sullivan FX, Vogelweid CM, Beschwilliford CL, Walker SE, 1995. Differential effects of CD4(+) T cell depletion on inflammatory central nervous system disease, arthritis and sialadenitis in MRL/lpr mice. J. Autoimmun. 8:163–175.

    PubMed  CAS  Google Scholar 

  • Owens T, 2003. The enigma of multiple sclerosis: inflammation and neurodegeneration cause heterogeneous dysfunction and damage. Curr. Opin. Neurol. 16:259–265.

    PubMed  Google Scholar 

  • Park C, Sakamaki K, Tachibana O, Yamashima T, Yamashita J, Yonehara S, 1998. Expression of Fas antigen in the normal mouse brain. Biochem. Biophys. Res. Commun. 252:623–628.

    PubMed  CAS  Google Scholar 

  • Parker LM, Chused TM, Steinberg AD, 1974. Immunofluorescence studies on thymocytotoxic antibody from New Zealand black mice. J. Immunol. 112:285.

    Google Scholar 

  • Patten SB, Svenson LW, Metz LM, 2005. Psychotic disorders in MS: population-based evidence of an association. Neurology 65:1123–1125.

    PubMed  Google Scholar 

  • Peress NS, Tompkins DC, 1979. Rat CNS in experimental chronic serum sickness: Integrity of the zonulae occludentes of the choroid plexus epithelium and brain endothelium in experimental chronic serum sickness. Neuropathol. Appl. Neurobiol. 5, 279–288.

    PubMed  CAS  Google Scholar 

  • Pollmacher T, Hinze-Selch D, Mullington J, 1996. Effects of clozapine on plasma cytokine and soluble cytokine receptor levels. J. Clin. Psychopharmacol. 16:403–409.

    PubMed  CAS  Google Scholar 

  • Quismorio FP, Friou GJ, 1972. Antibodies reactive with neurons in SLE patients with neuropsychiatric manifestations. Int. Arch. Allergy Appl. Immunol. 43:740–748.

    PubMed  CAS  Google Scholar 

  • Ramos M, Mandybur TI, 1975. Cerebral vasculitis in rheumatoid arthritis. Arch. Neurol. 32:271–275.

    PubMed  CAS  Google Scholar 

  • Rapaport MH, McAllister CG, 1991. Neuroimmunologic factors in schizophrenia. In: Gorman, J. M., Kertzner, R. M. (Eds.), Psychoimmunology Update. American Psychiatric Press, Washington, DC, pp. 31–54.

    Google Scholar 

  • Rhodes B, Vyse TJ, 2007. General aspects of the genetics of SLE. Autoimmunity 40: 550–559.

    PubMed  CAS  Google Scholar 

  • Rodier PM, 1994. Vulnerable periods and processes during central nervous system development. Environ. Health Perspect. 102 Suppl 2:121–124.

    Google Scholar 

  • Rothermundt M, Arolt V, Weitzsch C, Eckhoff D, Kirchner H, 1996. Production of cytokines in acute schizophrenic psychosis. Biol. Psychiatry 40:1294–1297.

    PubMed  CAS  Google Scholar 

  • Rudick RA, Eskin TA, 1983. Neuropathological features of a lupus-like disorder in autoimmune mice. Ann. Neurol. 14:325–332.

    PubMed  CAS  Google Scholar 

  • Ruiz-Argüelles A, Rivadeneyra-Espinoza L, Alarcón-Segovia D, 2003. Antibody penetration into living cells: pathogenic, preventive and immuno-therapeutic implications. Curr. Pharm. Des. 9:1881–1887.

    PubMed  Google Scholar 

  • Sa MJ, 2007. Psychological aspects of multiple sclerosis. Clin. Neurol. Neurosurg. (electronic publication).

    Google Scholar 

  • Sakic B, Denburg JA, Denburg SD, Szechtman H, 1996a. Blunted sensitivity to sucrose in autoimmune MRL-lpr mice: a curve-shift study. Brain Res. Bull. 41:305–311.

    CAS  Google Scholar 

  • Sakic B, Gurunlian L, Denburg SD, 1998a. Reduced aggressiveness and low testosterone levels in autoimmune MRL-lpr males. Physiol. Behav. 63:305–309.

    CAS  Google Scholar 

  • Sakic B, Kirkham DL, Ballok DA, Mwanjewe J, Fearon IM, Macri J, Yu G, Sidor MM, Denburg JA, Szechtman H, Lau J, Ball AK, Doering LC, 2005. Proliferating brain cells are a target of neurotoxic CSF in systemic autoimmune disease. J. Neuroimmunol. 169:68–85.

    PubMed  CAS  Google Scholar 

  • Sakic B, Kolb B, Whishaw IQ, Gorny G, Szechtman H, Denburg JA, 2000a. Immunosuppression prevents neuronal atrophy in lupus-prone mice: evidence for brain damage induced by autoimmune disease? J. Neuroimmunol. 111:93–101.

    CAS  Google Scholar 

  • Sakic B, Lacosta S, Denburg J, Szechtman H, 2002. Altered neurotransmission in brains of autoimmune mice: pharmacological and neurochemical evidence. J. Neuroimmunol. 129: 84–96.

    PubMed  CAS  Google Scholar 

  • Sakic B, Maric I, Koeberle PD, Millward JM, Szechtman H, Maric D, Denburg JA, 2000b. Increased TUNEL-staining in brains of autoimmune Fas-deficient mice. J. Neuroimmunol. 104:147–154.

    CAS  Google Scholar 

  • Sakic B, Szechtman H, Braciak TA, Richards CD, Gauldie J, Denburg JA, 1997a. Reduced preference for sucrose in autoimmune mice: a possible role of interleukin-6. Brain Res. Bull. 44:155–165.

    CAS  Google Scholar 

  • Sakic B, Szechtman H, Denburg JA, 1997b. Neurobehavioral alteration in autoimmune mice. Neurosci. Biobehav. Rev. 21:327–340.

    CAS  Google Scholar 

  • Sakic B, Szechtman H, Denburg SD, Carbotte RM, Denburg JA, 1993a. Brain-reactive antibodies and behavior of autoimmune MRL-lpr mice. Physiol. Behav. 54:1025–1029.

    CAS  Google Scholar 

  • Sakic B, Szechtman H, Denburg SD, Carbotte RM, Denburg JA, 1993b. Spatial learning during the course of autoimmune disease in MRL mice. Behav. Brain Res. 54:57–66.

    CAS  Google Scholar 

  • Sakic B, Szechtman H, Denburg JA, Gorny G, Kolb B, Whishaw IQ, 1998b. Progressive atrophy of pyramidal neuron dendrites in autoimmune MRL-lpr mice. J. Neuroimmunol. 87:162–170.

    CAS  Google Scholar 

  • Sakic B, Szechtman H, Gauldie J, Denburg JA, 2001. Behavioral effects of infection with IL-6 adenovector. Brain Behav. Immun. 15:25–42.

    PubMed  CAS  Google Scholar 

  • Sakic B, Szechtman H, Keffer M, Talangbayan H, Stead R, Denburg JA, 1992. A behavioral profile of autoimmune lupus-prone MRL mice. Brain Behav. Immun. 6:265–285.

    PubMed  CAS  Google Scholar 

  • Sakic B, Szechtman H, Stead R, Denburg JA, 1996b. Joint pathology and behavioral performance in autoimmune MRL-lpr mice. Physiol. Behav. 60:901–905.

    CAS  Google Scholar 

  • Sakic B, Szechtman H, Talangbayan H, Denburg SD, Carbotte RM, Denburg JA, 1994. Disturbed emotionality in autoimmune MRL-lpr mice. Physiol. Behav. 56:609–617.

    PubMed  CAS  Google Scholar 

  • Sasajima T, Watanabe H, Sato S, Sato Y, Ohira H, 2006. Anti-triosephosphate isomerase antibodies in cerebrospinal fluid are associated with neuropsychiatric lupus. J. Neuroimmunol. 181:150–156.

    PubMed  CAS  Google Scholar 

  • Scarisbrick IA, 2008. The multiple sclerosis degradome: enzymatic cascades in development and progression of central nervous system inflammatory disease. Curr. Top. Microbiol. Immunol. 318:133–175.

    CAS  Google Scholar 

  • Schiffer RB, Hoffman SA, 1991. Behavioral sequelae of autoimmune disease. In: Ader, R., Felten, D. L., Cohen, N. (Eds.), Psychoneuroimmunology. Academic Press, Inc., San Diego, CA, pp. 1037–1066.

    Google Scholar 

  • Schott K, Schaefer JE, Richartz E, Batra A, Eusterschulte B, Klein R, Berg PA, Bartels M, Mann K, Buchkremer G, 2003. Autoantibodies to serotonin in serum of patients with psychiatric disorders. Psychiatry Res. 121:51–57.

    PubMed  CAS  Google Scholar 

  • Schrott LM, Crnic LS, 1994. Sensitivity to foot shock in autoimmune NZB x NZW F1 hybrid mice. Physiol. Behav. 56:849–853.

    PubMed  CAS  Google Scholar 

  • Schrott LM, Crnic LS, 1996a. Anxiety behavior, exploratory behavior, and activity in NZB x NZW F1 hybrid mice: role of genotype and autoimmune disease progression. Brain Behav. Immun. 10:260–274.

    CAS  Google Scholar 

  • Schrott LM, Crnic LS, 1996b. The role of performance factors in the active avoidance conditioning deficit in autoimmune mice. Behav. Neurosci. 110:486–491.

    CAS  Google Scholar 

  • Schrott LM, Crnic LS, 1998. Attenuation of behavioral abnormalities in autoimmune mice by chronic soluble interferon-gamma receptor treatment. Brain Behav. Immun. 12:90–106.

    PubMed  CAS  Google Scholar 

  • Schrott LM, Denenberg VH, Sherman GF, Waters NS, Rosen GD, Galaburda AM, 1992. Environmental enrichment, neocortical ectopias, and behavior in the autoimmune NZB mouse. Dev. Brain Res. 67:85–93.

    CAS  Google Scholar 

  • Schrott LM, Morrison L, Wimer R, Wimer C, Behan PO, Denenberg VH, 1994. Autoimmunity and avoidance learning in NXRF recombinant inbred strains. Brain Behav. Immun. 8:100–110.

    PubMed  CAS  Google Scholar 

  • Schrott LM, Waters NS, Boehm GW, Sherman GF, Morrison L, Rosen GD, Galaburda AM, Denenberg VH, 1993. Behavior, cortical ectopias, and autoimmunity in BXSB-Yaa and BXSB-Yaa+ mice. Brain Behav. Immun. 7:205–223.

    PubMed  CAS  Google Scholar 

  • Schupf N, Williams CA, 1985. Effect of immune complex forming reactants on catecholaminemodulated behaviors in the rat hypothalamus. J. Neuroimmunol. 9:13–27.

    PubMed  CAS  Google Scholar 

  • Schupf N, Williams CA, 1987. Psychopharmacological activity of immune complexes in rat brain is complement dependent. J. Neuroimmunol. 13:293–303.

    PubMed  CAS  Google Scholar 

  • Schupf N, Williams CA, Hugli TE, Cox J, 1983. Psychopharmacological activity of anaphylatoxin C3a in rat hypothalamus. J. Neuroimmunol. 5:305–316.

    PubMed  CAS  Google Scholar 

  • Schwartz M, Silver H, 2000. Lymphocytes, autoantibodies and psychosis–coincidence versus etiological factor: an update. Isr. J. Psychiatry Relat. Sci. 37:32–36.

    PubMed  CAS  Google Scholar 

  • Scolding NJ, Joseph FG, 2002. The neuropathology and pathogenesis of systemic lupus erythematosus. Neuropathol. Appl. Neurobiol. 28:173–189.

    PubMed  CAS  Google Scholar 

  • Sherman GF, Galaburda AM, Behan PO, Rosen GD, 1987. Neuroanatomical anomalies in autoimmune mice. Acta Neuropathol. (Berl.) 74:239–242.

    CAS  Google Scholar 

  • Sherman GF, Morrison L, Rosen GD, Behan PO, Galaburda AM, 1990a. Brain abnormalities in immune defective mice. Brain Res. 532:25–33.

    CAS  Google Scholar 

  • Sherman GF, Stone JS, Press DM, Rosen GD, Galaburda AM, 1990b. Abnormal architecture and connections disclosed by neurofilament staining in the cerebral cortex of autoimmune mice. Brain Res. 529:202–207.

    CAS  Google Scholar 

  • Shiozawa S, Kuroki Y, Kim M, Hirohata S, Ogino T, 1992. Interferon-alpha in lupus psychosis. Arthritis Rheum. 35:417–422.

    PubMed  CAS  Google Scholar 

  • Shirai T, Mellors RC, 1971. Natural thymocytotoxic autoantibody and reactive antigen in New Zealand Black and other mice. Proc. Natl. Acad. Sci. U. S. A. 68:1412–1415.

    PubMed  CAS  Google Scholar 

  • Shirai T, Mellors RC, 1972. Natural cytotoxic autoantibody against thymocytes in NZB mice. Clin. Exp. Immunol. 12:133–152.

    PubMed  CAS  Google Scholar 

  • Shoenfeld Y, Aron-Maor A, 2000. Vaccination and autoimmunity-’vaccinosis’: a dangerous liaison? J. Autoimmun. 14:1–10.

    PubMed  CAS  Google Scholar 

  • Shucard JL, Parrish J, Shucard DW, McCabe DC, Benedict RH, Ambrus J, Jr., 2004. Working memory and processing speed deficits in systemic lupus erythematosus as measured by the paced auditory serial addition test. J. Int. Neuropsychol. Soc. 10:35–45.

    PubMed  Google Scholar 

  • Sibbitt WL, Haseler LJ, Griffey RH, Hart BL, Sibbitt RR, Matwiyoff NA, 1994. Analysis of cerebral structural changes in systemic lupus erythematosus by proton MR spectroscopy. AJNR Am. J. Neuroradiol. 15:923–928.

    PubMed  Google Scholar 

  • Sibbitt WL, Sibbitt RR, 1993. Magnetic resonance spectroscopy and positron emission tomography scanning in neuropsychiatric systemic lupus erythematosus. Rheum. Dis. Clin. North Am. 19:851–868.

    PubMed  Google Scholar 

  • Sidor MM, Sakic B, Malinowski PM, Ballok DA, Oleschuk CJ, Macri J, 2005. Elevated immunoglobulin levels in the cerebrospinal fluid from lupus-prone mice. J. Neuroimmunol. 165:104–113.

    PubMed  CAS  Google Scholar 

  • Silva SC, Correia C, Fesel C, Barreto M, Coutinho AM, Marques C, Miguel TS, Ataide A, Bento C, Borges L, Oliveira G, Vicente AM, 2004. Autoantibody repertoires to brain tissue in autism nuclear families. J. Neuroimmunol. 152:176–182.

    PubMed  CAS  Google Scholar 

  • Singer GG, Carrera AC, Marshakrothstein A, Martineza C, Abbas AK, 1994. Apoptosis, fas and systemic autoimmunity: The MRL-Ipr/Ipr model. Curr. Opin. Immunol. 6: 913–920.

    PubMed  CAS  Google Scholar 

  • Singh VK, 1996. Plasma increase of interleukin-12 and interferon-gamma. Pathological significance in autism. J. Neuroimmunol. 66:143–145.

    PubMed  CAS  Google Scholar 

  • Singh VK, Jensen RL, 2003. Elevated levels of measles antibodies in children with autism. Pediatr. Neurol. 28:292–294.

    PubMed  Google Scholar 

  • Singh VK, Lin SX, Newell E, Nelson C, 2002. Abnormal measles-mumps-rubella antibodies and CNS autoimmunity in children with autism. J. Biomed. Sci. 9: 359–364.

    PubMed  CAS  Google Scholar 

  • Singh VK, Rivas WH, 2004. Prevalence of serum antibodies to caudate nucleus in autistic children. Neurosci. Lett. 355:53–56.

    PubMed  CAS  Google Scholar 

  • Singh VK, Warren R, Averett R, Ghaziuddin M, 1997. Circulating autoantibodies to neuronal and glial filament proteins in autism. Pediatr. Neurol. 17:88–90.

    PubMed  CAS  Google Scholar 

  • Sirota P, Schild K, Elizur A, Djaldetti M, Fishman P, 1995. Increased interleukin-1 and interleukin- 3 like activity in schizophrenic patients. Prog. Neuropsychopharmacol. Biol. Psychiatry 19:75–83.

    PubMed  CAS  Google Scholar 

  • Sofat N, Malik O, Higgens C, 2006. Neurological involvement in patients with rheumatic disease. QJM 99:69–79.

    PubMed  CAS  Google Scholar 

  • Sokol DK, McIntyre JA, Wagenknecht DR, Dropcho EJ, Patel H, Salanova V, da Costa G, 2004. Antiphospholipid and glutamic acid decarboxylase antibodies in patients with focal epilepsy. Neurology 62:517–518.

    PubMed  CAS  Google Scholar 

  • Solomon GF, Allansmith M, McCellan B, Amkraut A, 1969. Immunoglobulins in psychiatric patients. Arch. Gen. Psychiatry 20:272–277.

    PubMed  CAS  Google Scholar 

  • Solomon GF, Moos RH, Fessel WJ, Morgan EE, 1966. Globulins and behavior in schizophrenia. Int. J. Neuropsychiatry 2:20–26.

    PubMed  CAS  Google Scholar 

  • Steens SC, Admiraal-Behloul F, Bosma GP, Steup-Beekman GM, Olofsen H, Le CS, Huizinga TW, van Buchem MA, 2004. Selective gray matter damage in neuropsychiatric lupus. Arthritis Rheum. 50:2877–2881.

    PubMed  CAS  Google Scholar 

  • Steiner JW, Gelbloom AJ, 1959. Intracranial manifestations in two cases of systemic rheumatoid disease. Arthritis Rheum. 2:537–545.

    PubMed  CAS  Google Scholar 

  • Stubbs EG, 1976. Autistic children exhibit undetectable hemagglutination-inhibition antibody titers despite previous rubella vaccination. J. Autism Child Schizophr. 6:269–274.

    PubMed  CAS  Google Scholar 

  • Szechtman H, Sakic B, Denburg JA, 1997. Behaviour of MRL mice: an animal model of disturbed behaviour in systemic autoimmune disease. Lupus 6:223–229.

    PubMed  CAS  Google Scholar 

  • Tanaka S, Matsunaga H, Kimura M, Tatsumi K, Hidaka Y, Takano T, Uema T, Takeda M, Amino N, 2003. Autoantibodies against four kinds of neurotransmitter receptors in psychiatric disorders. J. Neuroimmunol. 141:155–164.

    PubMed  CAS  Google Scholar 

  • Temesvari P, Denburg J, Denburg S, Carbotte R, Bensen W, Singal D, 1983. Serum lymphocytotoxic antibodies in neuropsychiatric lupus: A serial study. Clin. Immunol. Immunopathol. 28:243.

    PubMed  CAS  Google Scholar 

  • Theofilopoulos AN, 1992. Murine models of lupus. In: Lahita, R. G. (Ed.), Systemic Lupus Erythematosus. Churchill Livingstone, New York, pp. 121–194.

    Google Scholar 

  • Toh BH, Mackay IR, 1981. Autoantibody to a novel neuronal antigen in systemic lupus erythematosus and in normal human sera. Clin. Exp. Immunol. 44:555–559.

    PubMed  CAS  Google Scholar 

  • Tomer Y, Davies TF, 1995. Infections and autoimmune endocrine disease. Baillieres Best Pract. Res. Clin. Endocrinol. Metab. 9:47–70.

    CAS  Google Scholar 

  • Tomita M, Holman BJ, Santoro TJ, 2001a. Aberrant cytokine gene expression in the hippocampus in murine systemic lupus erythematosus. Neurosci. Lett. 302:129–132.

    CAS  Google Scholar 

  • Tomita M, Holman BJ, Williams LS, Pang KC, Santoro TJ, 2001b. Cerebellar dysfunction is associated with overexpression of proinflammatory cytokine genes in lupus. J. Neurosci. Res. 64:26–33.

    CAS  Google Scholar 

  • Tomita M, Khan RL, Blehm BH, Santoro TJ, 2004. The potential pathogenetic link between peripheral immune activation and the central innate immune response in neuropsychiatric systemic lupus erythematosus. Med. Hypotheses 62:325–335.

    PubMed  CAS  Google Scholar 

  • Torrey EF, Bartko JJ, Lun ZR, Yolken RH, 2007. Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis. Schizophr. Bull. 33:729–736.

    PubMed  Google Scholar 

  • Torrey EF, Leweke MF, Schwarz MJ, Mueller N, Bachmann S, Schroeder J, Dickerson F, Yolken RH, 2006. Cytomegalovirus and schizophrenia. CNS Drugs 20:879–885.

    PubMed  Google Scholar 

  • Torrey EF, Yolken RH, 2001. The schizophrenia-rheumatoid arthritis connection: infectious, immune, or both? Brain Behav. Immun. 15:401–410.

    PubMed  CAS  Google Scholar 

  • Toubi E, Khamashta MA, Panarra A, Hughes GRV, 1995. Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus. Am. J. Med. 99:397–401.

    PubMed  CAS  Google Scholar 

  • Toubi E, Shoenfeld Y, 2007. Clinical and biological aspects of anti-P-ribosomal protein autoantibodies. Autoimmun. Rev. 6:119–125.

    PubMed  CAS  Google Scholar 

  • Trottier G, Srivastava L, Walker CD, 1999. Etiology of infantile autism: a review of recent advances in genetic and neurobiological research. J. Psychiatry Neurosci. 24:103–115.

    PubMed  CAS  Google Scholar 

  • Trysberg E, Nylen K, Rosengren LE, Tarkowski A, 2003. Neuronal and astrocytic damage in systemic lupus erythematosus patients with central nervous system involvement. Arthritis Rheum. 48:2881–2887.

    PubMed  Google Scholar 

  • Trysberg E, Tarkowski A, 2004. Cerebral inflammation and degeneration in systemic lupus erythematosus. Curr. Opin. Rheumatol. 16:527–533.

    PubMed  Google Scholar 

  • Tsai CY, Wu TH, Tsai ST, Chen KH, Thajeb P, Lin WM, Yu HS, Yu CL, 1994. Cerebrospinal fluid interleukin-6, prostaglandin E2 and autoantibodies in patients with neuropsychiatric systemic lupus erythematosus and central nervous system infections. Scand. J. Rheumatol. 23:57–63.

    PubMed  CAS  Google Scholar 

  • Uhlig H, Dernick R, 1989. Monoclonal autoantibodies derived from multiple sclerosis patients and control persons and their reactivities with antigens of the central nervous system. Autoimmunity 5:87–99.

    PubMed  CAS  Google Scholar 

  • van Dam AP, Wekking EM, Callewaert JAC, Schipperijn AJM, Oomen HAPC, Dejong J, Swaak AJG, Smeenk RJT, Feltkamp TEW, 1994. Psychiatric symptoms before systemic lupus erythematosus is diagnosed. Rheumatol. Int. 14:57–62.

    PubMed  Google Scholar 

  • van Gent T, Heijnen CJ, Treffers PD, 1997. Autism and the immune system. J. Child Psychol. Psychiatry 38:337–349.

    PubMed  Google Scholar 

  • Vianello M, Tavolato B, Giometto B, 2002. Glutamic acid decarboxylase autoantibodies and neurological disorders. Neurol. Sci. 23:145–151.

    PubMed  CAS  Google Scholar 

  • Vincent A, Dalton P, Clover L, Palace J, Lang B, 2003. Antibodies to neuronal targets in neurological and psychiatric diseases. Ann. N. Y. Acad. Sci. 992:48–55.

    PubMed  CAS  Google Scholar 

  • Vogelweid CM, Johnson GC, Besch-Williford CL, Basler J, Walker SE, 1991. Inflammatory central nervous system disease in lupus-prone MRL/lpr mice: comparative histologic and immunohistochemical findings. J. Neuroimmunol. 35:89–99.

    PubMed  CAS  Google Scholar 

  • Vogelweid CM, Wright DC, Johnson JC, Hewett JE, Walker SE, 1994. Evaluation of memory, learning ability, and clinical neurologic function in pathogen-free mice with systemic lupus erythematosus. Arthritis Rheum. 37:889–897.

    PubMed  CAS  Google Scholar 

  • Volkow ND, Warner N, McIntyre R, Valentine A, Kulkarni M, Mullani N, Gould L, 1988. Cerebral involvement in systemic lupus erythematosus. Am. J. Physiol. Imaging 3:91–98.

    PubMed  CAS  Google Scholar 

  • Warren RP, Foster A, Margaretten NC, 1987. Reduced natural killer cell activity in autism. J. Am. Acad. Child Adolesc. Psychiatry 26:333–335.

    CAS  Google Scholar 

  • Warren RP, Margaretten NC, Pace NC, Foster A, 1986. Immune abnormalities in patients with autism. J. Autism Dev. Disord. 16:189–197.

    PubMed  CAS  Google Scholar 

  • Warren RP, Odell JD, Warren WL, Burger RA, Maciulis A, Daniels WW, Torres AR, 1996. Strong association of the third hypervariable region of HLA-DR beta 1 with autism. J. Neuroimmunol. 67:97–102.

    PubMed  CAS  Google Scholar 

  • Warren RP, Singh VK, 1996. Elevated serotonin levels in autism: association with the major histocompatibility complex. Neuropsychobiology 34:72–75.

    PubMed  CAS  Google Scholar 

  • Warren RP, Yonk J, Burger RW, Odell D, Warren WL, 1995. DR-positive T cells in autism: association with decreased plasma levels of the complement C4B protein. Neuropsychobiology 31:53–57.

    PubMed  CAS  Google Scholar 

  • Warren RP, Yonk LJ, Burger RA, Cole P, Odell JD, Warren WL, White E, Singh VK, 1990. Deficiency of suppressor-inducer (CD4 + CD45RA+) T cells in autism. Immunol. Invest. 19:245– 251.

    Google Scholar 

  • Waterloo K, Omdal R, Jacobsen EA, Klow NE, Husby G, Torbergsen T, Mellgren SI, 1999. Cerebral computed tomography and electroencephalography compared with neuropsychological findings in systemic lupus erythematosus. J. Neurol. 246:706–711.

    PubMed  CAS  Google Scholar 

  • Waterloo K, Omdal R, Sjoholm H, Koldingsnes W, Jacobsen EA, Sundsfjord JA, Husby G, Mellgren SI, 2001. Neuropsychological dysfunction in systemic lupus erythematosus is not associated with changes in cerebral blood flow. J. Neurol. 248:595–602.

    PubMed  CAS  Google Scholar 

  • Wekking EM, 1993. Psychiatric symptoms in systemic lupus erythematosus – an update. Psychosom. Med. 55:219–228.

    PubMed  CAS  Google Scholar 

  • Wekking EM, Nossent JC, van Dam AP, Swaak AJ, 1991. Cognitive and emotional disturbances in systemic lupus erythematosus. Psychother. Psychosom. 55:126–131.

    PubMed  CAS  Google Scholar 

  • Wilke I, Arolt V, Rothermundt M, Weitzsch C, Hornberg M, Kirchner H, 1996. Investigations of cytokine production in whole blood cultures of paranoid and residual schizophrenic patients. Eur. Arch. Psychiatry Clin. Neurosci. 246:279–284.

    PubMed  CAS  Google Scholar 

  • Williams GW, Bluestein HG, Steinberg AD, 1981. Brain-reactive lymphocytotoxic antibody in the cerebrospinal fluid of patients with systemic lupus erythematosus: correlation with central nervous system involvement. Clin. Immunol. Immunopathol. 18:126–132.

    PubMed  CAS  Google Scholar 

  • Williams CA, Schupf N, 1977. Antigen-antibody reactions in rat brain sites induce transient changes in drinking behavior. Science 196:328–331.

    PubMed  CAS  Google Scholar 

  • Williams CA, Schupf N, Hugli TE, 1985. Anaphylatoxin C5a modulation of an alpha-adrenergic receptor system in the rat hypothalamus. J. Neuroimmunol. 9:29–40.

    PubMed  CAS  Google Scholar 

  • Williams CA, Schupf N, Reilly CL, Wagner J, 1988. Complement peptides and neuronal dysfunction in the central nervous system – specificity of receptor sites for anapylatoxin C3a activity in the rat hypothalamus. Drug Dev. Res. 15:175–187.

    CAS  Google Scholar 

  • Wilson HA, Winfield JB, Lahita RG, Koffler D, 1979. Autoantibody to a novel neuronal antigen in systemic lupus erythematosus and in normal human sera. Arthritis Rheum. 22:458–462.

    PubMed  CAS  Google Scholar 

  • Winfield JB, Brunner CM, Koffler D, 1978. Serologic studies in patients with systemic lupus erythematosus and central nervous system dysfunction. Arthritis Rheum. 21:289–294.

    PubMed  CAS  Google Scholar 

  • Winfield JB, Shaw M, Silverman LM, Eisenberg RA, Wilson HA, III, Koffler D, 1983. Intrathecal IgG synthesis and blood-brain barrier impairment in patients with systemic lupus erythematosus and central nervous system dysfunction. Am. J. Med. 74:837–844.

    PubMed  CAS  Google Scholar 

  • Yolken R, 2004. Viruses and schizophrenia: a focus on herpes simplex virus. Herpes 11 Suppl 2:83A–88A.

    PubMed  Google Scholar 

  • Yonk LJ, Warren RP, Burger RA, Cole P, Odell JD, Warren WL, White E, 1990. CD4+ helper T cell depression in autism. Immunol. Lett. 25:341–345.

    PubMed  CAS  Google Scholar 

  • Yoshida A, Shishido F, Kato K, Watanabe H, Seino O, 2007. Evaluation of cerebral perfusion in patients with neuropsychiatric systemic lupus erythematosus using 123I-IMP SPECT. Ann. Nucl. Med. 21:151–158.

    PubMed  Google Scholar 

  • Yoshio T, Hirata D, Onda K, Nara H, Minota S, 2005. Antiribosomal P protein antibodies in cerebrospinal fluid are associated with neuropsychiatric systemic lupus erythematosus. J. Rheumatol. 32:34–39.

    PubMed  CAS  Google Scholar 

  • Zameer A, Hoffman SA, 2001. Immunoglobulin binding to brain in autoimmune mice. J. Neuroimmunol. 120:10–18.

    PubMed  CAS  Google Scholar 

  • Zameer A, Hoffman SA, 2003. Increased ICAM-1 and VCAM-1 expression in the brains of autoimmune mice. J. Neuroimmunol. 142:67–74.

    PubMed  CAS  Google Scholar 

  • Zameer A, Hoffman SA, 2004. B and T cells in the brains of autoimmune mice. J. Neuroimmunol. 146:133–139.

    PubMed  CAS  Google Scholar 

  • Zandman-Goddard G, Chapman J, Shoenfeld Y, 2007. Autoantibodies involved in neuropsychiatric SLE and antiphospholipid syndrome. Semin. Arthritis Rheum. 36:297–315.

    CAS  Google Scholar 

  • Zimmerman AW, Frye VH, Potter NT, 1993. Immunological aspects of autism. Int. Pediatr. 8:161–166.

    Google Scholar 

  • Ziv Y, Schwartz M, 2008. Immune-based regulation of adult neurogenesis: implications for learning and memory. Brain Behav. Immun. 22:167–176.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. College of Liberal Arts and Sciences School of Life Sciences Neuroimmunology Labs, Arizona State University, PO Box 874501, Tempe, AZ 85287–4501, USA

    Steven A. Hoffman

Authors
  1. Steven A. Hoffman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Boris Sakic
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Departments of Neurology and Neuroscience and Psychiatry, University of Medicine and Dentistry of New Jersey — NJ Medical School, Newark, NJ 07103, USA

    Allan Siegel

  2. University of Medicine and Dentistry of New Jersey — NJ Medical School, Newark, NJ 07103, USA

    Steven S. Zalcman

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Hoffman, S.A., Sakic, B. (2009). Autoimmunity and Brain Dysfunction. In: Siegel, A., Zalcman, S.S. (eds) The Neuroimmunological Basis of Behavior and Mental Disorders. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-84851-8_17

Download citation

Publish with us

Policies and ethics

Search

Navigation